Copper is an essential element for living organisms, being a cofactor for numerous enzymes or proteins involved in oxidation-reduction reactions, intervening in numerous metabolic processes. In recent decades, complex copper combinations have consolidated their position in medicinal chemistry, which is manifested by the increasing number of compounds that have demonstrated their efficacy following in vitro or in vivo testing. While attempting to mimic the DNA-metal complex interactions typical of cisplatin, most studies of the mechanisms of action of copper complexes continue to consider DNA as the main biological target. Starting from this, studies are focused on understanding in detail how copper complexes manage to destroy tumor cells, and this has led to the discovery of a wide range of such mechanisms of antitumor action. In this review we present the main mechanisms of action of copper complexes discovered in recent decades, from the most well-known (production of ROS following the reaction with DNA) to the newest (cuproptosis). Research into understanding the mechanisms of action of copper complexes continues to be a topic of great interest in developing new potential antitumor agents.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic progressive liver disease with a substantial impact on global health. Given that MASLD has a complex etiology, it is a multisystemic disease, a multidisciplinary approach is required when treating MASLD. The optimal drug for MASLD should diminish steatosis, fibrosis and inflammation in the liver. Although the pharmaceutical industry is still lagging in developing an approved pharmacologic therapy for MASLD, research has recently intensified, and many molecules that are in the final stages of clinical trials are expected to be approved in the coming few years. The current review updated information related to the MASLD pathogenesis, diagnosis and therapeutic options, how patients are clinically managed nowadays, and what to expect in the near future.

Nowadays, nonalcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver disorder worldwide. From the clinical point of view, it evolves from steatosis to nonalcoholic steatohepatitis, which can lead to cirrhosis and finally to hepatocellular carcinoma. The mechanisms involved in its progression to more pathological stages and NAFLD pathogenesis are not completely understood. The research concerning NAFLD has become urgent and important because the age of NAFLD diagnosis is progressively decreasing, and its relationship with cancer risk is already well known. Because NAFLD ultimately leads to disability and imposes a major socioeconomic burden, timely diagnosis and effective treatment of NAFLD is particularly important. In the development of NAFLD, noncoding RNAs (ncRNAs) represented by microRNAs, long noncoding RNAs, circular RNAs, and piRNAs are epigenetic factors that play important regulatory roles. In the current review, we present updated information regarding the role of miRNAs, lncRNAs, circRNAs, and piRNAs, aiming to develop a good understanding of their regulatory functions in hepatic metabolism and concerning their potential use as biomarkers for early NAFLD/NASH diagnosis and as therapeutic targets.

In recent decades, Blanket Dry Cow Therapy (BDCT) has been regarded as a cornerstone strategy for the control of mastitis in dairy cows during the dry period. However, concerns regarding the rising incidence of antibiotic resistance and the associated zoonotic risks have prompted a paradigm shift, leading to intensified research into alternative management approaches. In response, many countries have adopted a more targeted approach, known as Selective Dry Cow Therapy (SDCT), which focuses on the therapeutic use of antibiotics, administered only to cows or quarters that are either infected or at high risk of infection during the dry period. This review provides a comprehensive synthesis of the scientific literature regarding the main methods for selecting animals for SDCT, the impact of this strategy on udder health, milk production, farm economics, and antibiotic consumption, as well as the factors that may influence its effectiveness. Over time, a range of methods have been developed to identify infected animals, including bacteriological culture, somatic cell count (SCC), differential somatic cell count (DSCC), and the California Mastitis Test (CMT), which are often used alone or in combination with clinical mastitis history and/or parity. Among these methods, SCC has proven to be the most economically viable and best suited for practical use, while its combination with DSCC has been shown to significantly enhance diagnostic accuracy. According to the studies reviewed, SDCT is a safe and effective strategy for maintaining udder health and farm profitability, as long as infected cows are accurately identified, and internal teat sealants are used in quarters not treated with antibiotics during the dry period. However, since udder health is influenced by herd characteristics, management practices, and regional pathogens, the findings cannot be universally applied and must be adapted to each herd’s specific conditions.

Polymorphisms in the Toll-like receptor 4 (TLR4) and IL-17 cytokine genes play a role in liver fibrosis progression among patients with MASLD. The current study aimed to investigate whether the IL17 (A7448G and G197A) and TLR4 (Asp299Gly and Thr399Ile) gene polymorphisms are associated with increased liver fibrosis stages in MASLD patients. Genotyping for the IL17F-A7488G, IL17A-G197A, TLR4-Asp299Gly, and TLR4-Thr399Ile polymorphisms was performed on a sample of 42 MASLD patients and 39 healthy controls. Serum levels of IL17F, IL17A, and TLR4 were measured using ELISA techniques. Bivariate analysis revealed significant associations between glycemic levels (p = 0.006), lipid metabolism (total cholesterol, HDL cholesterol, triglycerides), and the severity of liver fibrosis (p < 0.05). The IL17A-G197A GA and AA genotypes were more frequent in patients with advanced liver fibrosis compared to those without fibrosis (GA genotype frequency: 42.9% vs. 7.7%; AA genotype frequency: 14.3% vs. 5.1%; adjusted p = 0.0423). In the multivariable ordinal logistic regression, the IL17A-G197A polymorphism remained significantly associated with higher liver fibrosis stages (adjusted p = 0.0155). Patients with the dominant genotype (GA + AA) of the IL17A-G197A polymorphism exhibited 3.91 times greater odds of experiencing at least a one-stage increase in liver fibrosis compared to those with the GG genotype (adjusted OR = 3.91, 95% CI: 1.33–12.34). This study indicates that IL17-related genetic polymorphisms and metabolic characteristics significantly affect liver fibrosis progression in MASLD patients, with the IL17A-G197A gene polymorphism identified as an independent multivariate predictor of fibrosis progression.

This study evaluated the biological and economic impact of twin calvings in a commercial dairy herd located in Harghita County, Romania. Data from 2019 to 2022 were analyzed retrospectively using production, reproductive, and veterinary records. The incidence of twin pregnancies averaged 11.0% across the study period. Mixed-sex pairs were most frequent (55.3%), followed by female–female (28.2%) and male–male (16.5%) combinations. Twin calvings were associated with significant reductions in subsequent milk yield (−742 kg per lactation; p < 0.05), decreased fertility (2.3 vs. 1.4 inseminations; 103 vs. 79 days service period; p < 0.05), and higher veterinary costs (EUR 90 per case). The expected loss of replacement value due to freemartinism was EUR 63 per twin calving. After accounting for a small gain in calf value, the total economic loss was estimated at EUR 379 per twin calving. These findings demonstrate that twin pregnancies, although relatively uncommon, substantially reduce productive efficiency and profitability in dairy systems. Early detection and targeted reproductive management are recommended to mitigate their adverse effects and enhance farm sustainability.